Osage Partners related stories
All articles and analysis
PsiKick raises $16.5 mlnPsiKick said Wednesday that it raised $16.5 million in Series B financing led by Osage University Partners. Also participating were existing investors New Enterprise Associates, the University of Michigan Investment in New Technologies Fund (MINTS), as well as individual angels. PsiKick, of Santa Clara, California, is developing wireless, self-powering Internet of Things systems.
- eFFECTOR Therapeutics nabs $40 mln Series B
San Diego-based eFFECTOR Therapeutics, a biopharmaceutical company focused on treating cancer, has raised $40 million in Series B funding. The investors were Altitude Life Science Ventures, AbbVie Biotech Ventures, BioMed Ventures, Abingworth, Novartis Venture Fund, SR One, The Column Group, US Venture Partners, Astellas Ventures, Osage University Partners and Mission Bay Capital. In addition to the funding, eFFECTOR has named Dave Maki, managing partner of Altitude Life Science Ventures, to its board of directors.
- Sidecar pulls in $8 mln in Ascent Venture Partners-led round
Sidecar, a provider of ecommerce marketing technology, has closed $8 million in Series B funding. Ascent Venture Partners led the round with participation from other investors that included Osage Venture Partners.
- VC-backed Mirna Therapeutics debuts IPO
Austin, Texas-based Mirna Therapeutics Inc, a biopharmaceutical company focused on developing cancer-treating drugs, has raised almost $44 million for its IPO after pricing its 6.25 million shares at $7 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol "MIRN." Citigroup and Leerink Partners are the lead underwriters. Mirna's backers included Sofinnova Ventures, New Enterprise Associates, Pfizer Ventures, Osage University Partners and Correlation Ventures.
- SevOne racks up $50 mln Series C
SevOne, a provider of digital infrastructure management solutions, has raised $50 million in Series C funding. Westfield Capital Management and Bain Capital Ventures led the round with participation from Brookside Capital, HarbourVest, VT Technology Ventures and Osage Venture Partners.
- Selecta Biosciences raises $38 mln
Selecta Biosciences Inc. said Tuesday it raised $38 million in a Series E financing round. OrbiMed is the largest investor in the round which includes new investors, Sanofi-Genzyme BioVentures, Ridgeback Capital Management, Osage University Partners, AJU IB Investment and Sphera Global Health Care Fund. All of Selecta’s existing investors also participated. Watertown, Massachusetts-based Selecta is clinical stage biotechnology company.
- PeopleLinx reels in $3.5 mln
Philadelphia-based PeopleLinx, which provides solutions that improve buyer engagement, has raised $3.5 million in funding. The investors were Osage Venture Partners, Greycroft Partners and MissionOG.
- Osage University Partners adds to team
Osage University Partners has hired Kirsten Leute as senior vice president of university relations. Previously, Leute worked at Stanford University where she served as an associate director of the office of technology licensing.